Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Alegent Health / Bergan Mercy Hospital
mi
from
Omaha, NE
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Alegent Health / Bergan Mercy Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Creighton University
mi
from
Omaha, NE
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Catholic Medical Center
mi
from
Manchester, NH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Catholic Medical Center
mi
from
Manchester, NH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Cooper University Hospital
mi
from
Camden, NJ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Cardiovascular Associates of the Delaware Valley, PA
mi
from
Haddon Heights, NJ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Cardiovascular Associates of the Delaware Valley, PA
mi
from
Haddon Heights, NJ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Michaels Hospital
mi
from
Newark, NJ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Michaels Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Presbyterian Heart Group
mi
from
Albuquerque, NM
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Presbyterian Heart Group
mi
from
Albuquerque, NM
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sjh Cardiology Associates
mi
from
Liverpool, NY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sjh Cardiology Associates
mi
from
Liverpool, NY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Winthrop University Hospital
mi
from
Mineola, NY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Westchester Medical Center
mi
from
Valhalla, NY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Asheville Cardiology Associates
mi
from
Asheville, NC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Asheville Cardiology Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Carolina Heart Specialists
mi
from
Gastonia, NC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Carolina Heart Specialists
mi
from
Gastonia, NC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Carolina Cardiology Associates
mi
from
High Point, NC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Carolina Cardiology Associates
mi
from
High Point, NC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Wake Heart Association
mi
from
Raleigh, NC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Wake Heart Association
mi
from
Raleigh, NC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Forsyth Medical Center
mi
from
Winston-Salem, NC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
MeritCare Medical Center
mi
from
Fargo, ND
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
MeritCare Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Altru Health System
mi
from
Grand Forks, ND
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Altru Health System
mi
from
Grand Forks, ND
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Elyria Memorial Hospital
mi
from
Elyria, OH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Elyria Memorial Hospital
mi
from
Elyria, OH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Northwest Ohio Cardiology
mi
from
Toledo, OH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Northwest Ohio Cardiology
mi
from
Toledo, OH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Midwest Regional Medical Center
mi
from
Midwest City, OK
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Midwest Regional Medical Center
mi
from
Midwest City, OK
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Oklahoma Foundation for CV Research
mi
from
Oklahoma City, OK
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Oklahoma Foundation for CV Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Abington Memorial Hospital
mi
from
Abington, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Chambersburg Hospital
mi
from
Chambersburg, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Chambersburg Hospital
mi
from
Chambersburg, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Geisinger Clinic
mi
from
Danville, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Geisinger Clinic
mi
from
Danville, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Doylestown Hospital
mi
from
Doylestown, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Conemaugh Memorial Medical Center
mi
from
Johnstown, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Conemaugh Memorial Medical Center
mi
from
Johnstown, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Donald Guthrie Foundation for Education and Research
mi
from
Sayre, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Donald Guthrie Foundation for Education and Research
mi
from
Sayre, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Berks Cardiologists
mi
from
Wyomissing, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Berks Cardiologists
mi
from
Wyomissing, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Rhode Island Hospital
mi
from
Providence, RI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
North Central Heart Institute
mi
from
Sioux Falls, SD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
North Central Heart Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sanford USD Medical Center
mi
from
Sioux Falls, SD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Chattanooga Heart Institute
mi
from
Chattanooga, TN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Chattanooga Heart Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Capital Cardiovascular Research Institute
mi
from
Austin, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Capital Cardiovascular Research Institute
mi
from
Austin, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Texas Cardiovascular
mi
from
Austin, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Texas Cardiovascular
mi
from
Austin, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
CRSTI Research
mi
from
Dallas, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
CRSTI Research
mi
from
Dallas, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
North Dallas Research Associate
mi
from
McKinney, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
North Dallas Research Associate
mi
from
McKinney, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
The Heart Hospital Baylor Plano
mi
from
Plano, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Scott & White Healthcare-Round Rock
mi
from
Round Rock, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Scott & White Healthcare-Round Rock
mi
from
Round Rock, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
TexSan Heart Hospital
mi
from
San Antonio, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
TexSan Heart Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Mother Frances Hospital
mi
from
Tyler, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Mother Frances Hospital
mi
from
Tyler, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Providence Healthcare Network
mi
from
Waco, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Providence Healthcare Network
mi
from
Waco, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Intermountain Medical Center
mi
from
Murray, UT
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
University of Virginia
mi
from
Charlottesville, VA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Rockingham Memorial Hospital
mi
from
Harrisonburg, VA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Rockingham Memorial Hospital
mi
from
Harrisonburg, VA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Lynchburg General Hospital
mi
from
Lynchburg, VA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Lynchburg General Hospital
mi
from
Lynchburg, VA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Carilion Clinic
mi
from
Roanoke, VA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Carilion Clinic
mi
from
Roanoke, VA
Click here to add this to my saved trials